Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

The most common cancer-causing strain of human papillomavirus, HPV16, undermines the body’s defenses by reprogramming immune cells surrounding the tumor, according to a preclinical study from researchers at the Keck School of Medicine of USC. In mice, blocking this process boosted the ability of experimental treatments for HPV to eliminate cancer cells.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Mayo Clinic researchers have established the world’s first biobank of human salivary gland tissue-organoids to study chronic dry mouth, or xerostomia, an agonizing side effect of damaged salivary glands that affects millions.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

An international clinical trial co-led by WashU Medicine found that the immunotherapy drug pembrolizumab (Keytruda) added to standard-of-care therapy improved survival for patients with locally advanced head-and-neck cancer.

May 02, 2025

Vol.51 No.17

Clinical Roundup

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus-negative head-and-neck squamous cell carcinoma. More than half of study participants had 50% or more of their tumors shrink after receiving the immunotherapy drug nivolumab with chemotherapy, followed by response-adaptive chemo-radiation therapy.

March 14, 2025

Vol.51 No.10

Clinical

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

Each year, nearly 14 million people in the U.S. contract human papillomavirus, a common, sexually-transmitted virus that can cause several cancers.

March 07, 2025

Vol.51 No.09

By Claire Marie Porter

Clinical Roundup

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Cedars-Sinai performed the first robot-assisted microsurgical head-and-neck cancer reconstructive surgery in the United States after the robot device received FDA approval for the procedure.

February 21, 2025

Vol.51 No.07

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

YOU MAY BE INTERESTED IN

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Renew today!

Subscriber content

Never miss an issue!

Login

Henry Ford + MSU researchers granted $3M from NIH to study HPV-positive head-and-neck cancers

YOU MAY BE INTERESTED IN

Preclinical study reveals how HPV reprograms immune cells to help cancer grow

Mayo Clinic researchers develop first salivary gland regenerative biobank to combat chronic dry mouth

Pembro + standard-of-care improves survival in locally advanced head-and-neck cancer

Chemo-immunotherapy approach shows potential benefit in advanced HPV-negative head-and-neck cancer

Survey reveals most Americans are uninformed about HPVA vaccine can prevent cancer—most people don’t take it

First FDA-approved robot-assisted microsurgery for head-and-neck cancer performed at Cedars-Sinai

Never miss an issue!

Login

Survey reveals most Americans are uninformed about HPV
A vaccine can prevent cancer—most people don’t take it